Enrolling By Invitation NA INTERVENTIONAL 2-arm NCT06837064

Efficacy of Chatbot for Irritable Bowel Syndrome (IBS) Patients (IrBiS)

Evaluation of the Efficacy of Chatbot-based Automated Support System for Patients with Irritable Bowel Syndrome (IBS)

Sponsor: I.M. Sechenov First Moscow State Medical University

Conditions Irritable Bowel Syndrome Irritable Bowel Syndrome - Constipation Irritable Bowel Syndrome - Diarrhoea Irritable Bowel Syndrome - Mixed

Interventions Chatbot supporting system

Updated 2 times since 2025 Last updated: Feb 14, 2025 Started: Mar 31, 2025 Primary completion: May 31, 2025 Completion: Aug 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Irritable Bowel Syndrome and Irritable Bowel Syndrome - Constipation, this trial is ongoing. The trial is conducted by I.M. Sechenov First Moscow State Medical University and has accumulated 2 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Enrolling By Invitation NA
Mar 2025 — Sep 2025 [monthly]

Enrolling By Invitation NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

I.M. Sechenov First Moscow State Medical University
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department

Data source: Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Moscow, Russia